Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H20F2N4 |
| Molecular Weight | 402.4392 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC(=CC(F)=C1CNC2CC3=C(C2)C=CC=C3)C4=CC=CC(=C4)C5=NNC=N5
InChI
InChIKey=WIEDUMBCZQRGSY-UHFFFAOYSA-N
InChI=1S/C24H20F2N4/c25-22-11-19(15-6-3-7-18(8-15)24-28-14-29-30-24)12-23(26)21(22)13-27-20-9-16-4-1-2-5-17(16)10-20/h1-8,11-12,14,20,27H,9-10,13H2,(H,28,29,30)
GSK-1521498 is being tested for treatment of over-eating behaviors and other control-related eating problems. This compound inhibits the effects of opioids, which are known to be involved in controlling how much we eat and the pleasure associated with eating. GSK-1521498 has also been evaluated for treatment of alcoholism, potentially promoting abstinence and preventing relapse in alcohol addiction.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
24737629
Created by
admin on Mon Mar 31 21:21:15 GMT 2025 , Edited by admin on Mon Mar 31 21:21:15 GMT 2025
|
PRIMARY | |||
|
DTXSID40143501
Created by
admin on Mon Mar 31 21:21:15 GMT 2025 , Edited by admin on Mon Mar 31 21:21:15 GMT 2025
|
PRIMARY | |||
|
W0UTB622GK
Created by
admin on Mon Mar 31 21:21:15 GMT 2025 , Edited by admin on Mon Mar 31 21:21:15 GMT 2025
|
PRIMARY | |||
|
1007573-18-3
Created by
admin on Mon Mar 31 21:21:15 GMT 2025 , Edited by admin on Mon Mar 31 21:21:15 GMT 2025
|
PRIMARY | |||
|
DB12886
Created by
admin on Mon Mar 31 21:21:15 GMT 2025 , Edited by admin on Mon Mar 31 21:21:15 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
